Form 4 filings across 4 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$2.5M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 14 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 29 most recent Form 4 transactions.
| +53.0% |
| Open the original filing on SEC.gov |
| Jul 28 | NBIX | Neurocrine Biosciences INC | SSELL◷ | 1,250 | $182.01 | $227.5K | -44.0% | Open the original filing on SEC.gov |
| Jun 24 | ARVN | Arvinas, INC. | AGRANT◆ | 22,714 | — | — | — | Open the original filing on SEC.gov |
| Jun 24 | ARVN | Arvinas, INC. | AGRANT | 15,527 | — | — | +59.6% | Open the original filing on SEC.gov |
| Jun 4 | NBIX | Neurocrine Biosciences INC | SSELL◷ | 1,250 | $168.06 | $210.1K | -30.6% | Open the original filing on SEC.gov |
| May 27 | NBIX | Neurocrine Biosciences INC | AGRANT◆ | 2,624 | — | — | — | Open the original filing on SEC.gov |
| May 27 | NBIX | Neurocrine Biosciences INC | AGRANT◆ | 1,284 | — | — | — | Open the original filing on SEC.gov |
| May 21 | NBIX | Neurocrine Biosciences INC | MEXER◆ | 1,659 | — | — | — | Open the original filing on SEC.gov |
| May 21 | NBIX | Neurocrine Biosciences INC | MEXER | 1,659 | — | — | +68.3% | Open the original filing on SEC.gov |
| May 14 | CVS | CVS HEALTH Corp | AGRANT | 1,447 | $97.15 | $140.6K | +24.4% | Open the original filing on SEC.gov |
| May 12 | NBIX | Neurocrine Biosciences INC | SSELL◷ | 3,810 | $155.01 | $590.6K | -61.1% | Open the original filing on SEC.gov |
| Jan 21 | GMED | Globus Medical INC | AGRANT◆ | 15,000 | — | — | — | Open the original filing on SEC.gov |
| Jan 8 | GMED | Globus Medical INC | SSELL◷ | 2,000 | $101.10 | $202.2K | -16.1% | Open the original filing on SEC.gov |
| Dec 16, 2025 | NBIX | Neurocrine Biosciences INC | SSELL◷ | 1,190 | $155.09 | $184.6K | -16.0% | Open the original filing on SEC.gov |
| Dec 15, 2025 | NBIX | Neurocrine Biosciences INC | MEXER◷◆ | 1,724 | — | — | — | Open the original filing on SEC.gov |
| Dec 15, 2025 | NBIX | Neurocrine Biosciences INC | MEXER◷◆ | 8,276 | — | — | — | Open the original filing on SEC.gov |
| Dec 15, 2025 | NBIX | Neurocrine Biosciences INC | SSELL◷ | 5,000 | $152.23 | $761.1K | -40.2% | Open the original filing on SEC.gov |
| Dec 15, 2025 | NBIX | Neurocrine Biosciences INC | MEXER◷ | 1,724 | $84.95 | $146.5K | +16.1% | Open the original filing on SEC.gov |
| Dec 15, 2025 | NBIX | Neurocrine Biosciences INC | MEXER◷ | 8,276 | $92.35 | $764.3K | +340.7% | Open the original filing on SEC.gov |
| Dec 12, 2025 | GMED | Globus Medical INC | SSELL◷ | 4,000 | $88.85 | $355.4K | -24.4% | Open the original filing on SEC.gov |
| Nov 20, 2025 | CVS | CVS HEALTH Corp | AGRANT | 1,652 | $76.04 | $125.6K | +38.6% | Open the original filing on SEC.gov |
| Jun 25, 2025 | ARVN | Arvinas, INC. | AGRANT◆ | 23,105 | — | — | — | Open the original filing on SEC.gov |
| Jun 25, 2025 | ARVN | Arvinas, INC. | AGRANT | 16,025 | — | — | +159.9% | Open the original filing on SEC.gov |
| May 22, 2025 | NBIX | Neurocrine Biosciences INC | MEXER◆ | 1,435 | — | — | — | Open the original filing on SEC.gov |
| May 22, 2025 | NBIX | Neurocrine Biosciences INC | MEXER | 1,435 | — | — | +144.4% | Open the original filing on SEC.gov |
| May 21, 2025 | NBIX | Neurocrine Biosciences INC | AGRANT◆ | 3,305 | — | — | — | Open the original filing on SEC.gov |
| May 21, 2025 | NBIX | Neurocrine Biosciences INC | AGRANT◆ | 1,659 | — | — | — | Open the original filing on SEC.gov |
| May 15, 2025 | CVS | CVS HEALTH Corp | AGRANT | 2,077 | $60.47 | $125.6K | +94.4% | Open the original filing on SEC.gov |